186 related articles for article (PubMed ID: 23361242)
1. Overexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer.
Ning J; Zhang J; Liu W; Lang Y; Xue Y; Xu S
Eur J Histochem; 2012 Nov; 56(4):e46. PubMed ID: 23361242
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics.
Yang M; Liu YD; Wang YY; Liu TB; Ge TT; Lou G
Tumour Biol; 2014 Feb; 35(2):929-34. PubMed ID: 23979981
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer.
Zhang Y; Yao L; Zhang X; Ji H; Wang L; Sun S; Pang D
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1245-53. PubMed ID: 21691749
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of USP22 as an oncogene in papillary thyroid carcinoma.
Wang H; Li YP; Chen JH; Yuan SF; Wang L; Zhang JL; Yao Q; Li NL; Bian JF; Fan J; Yi J; Ling R
Tumour Biol; 2013 Jun; 34(3):1635-9. PubMed ID: 23412977
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-specific peptidase 22, a histone deubiquitinating enzyme, is a novel poor prognostic factor for salivary adenoid cystic carcinoma.
Dai W; Yao Y; Zhou Q; Sun CF
PLoS One; 2014; 9(1):e87148. PubMed ID: 24466336
[TBL] [Abstract][Full Text] [Related]
6. USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
Int J Oncol; 2014 Oct; 45(4):1594-608. PubMed ID: 24993031
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression.
Sun T; Zhang K; Li W; Liu Y; Pangeni RP; Li A; Arvanitis L; Raz DJ
Cell Commun Signal; 2022 Sep; 20(1):147. PubMed ID: 36123698
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-30e-5p suppresses non-small cell lung cancer tumorigenesis by regulating USP22-mediated Sirt1/JAK/STAT3 signaling.
Xu G; Cai J; Wang L; Jiang L; Huang J; Hu R; Ding F
Exp Cell Res; 2018 Jan; 362(2):268-278. PubMed ID: 29174979
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-specific protease 22: a novel molecular biomarker in glioma prognosis and therapeutics.
Liang J; Zhang X; Xie S; Zhou X; Shi Q; Hu J; Wang W; Qi W; Yu R
Med Oncol; 2014 Apr; 31(4):899. PubMed ID: 24573640
[TBL] [Abstract][Full Text] [Related]
10. USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma.
Piao S; Liu Y; Hu J; Guo F; Ma J; Sun Y; Zhang B
PLoS One; 2012; 7(8):e42540. PubMed ID: 22880026
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer.
Hu J; Liu YL; Piao SL; Yang DD; Yang YM; Cai L
Lung Cancer; 2012 Sep; 77(3):593-9. PubMed ID: 22717106
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer.
Liu YL; Yang YM; Xu H; Dong XS
J Surg Oncol; 2011 Mar; 103(3):283-9. PubMed ID: 21337558
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer.
Liu YL; Yang YM; Xu H; Dong XS
J Gastroenterol Hepatol; 2010 Nov; 25(11):1800-5. PubMed ID: 21039844
[TBL] [Abstract][Full Text] [Related]
14. Decreased H2B monoubiquitination and overexpression of ubiquitin-specific protease enzyme 22 in malignant colon carcinoma.
Wang Z; Zhu L; Guo T; Wang Y; Yang J
Hum Pathol; 2015 Jul; 46(7):1006-14. PubMed ID: 25971547
[TBL] [Abstract][Full Text] [Related]
15. Expression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinoma.
Tang B; Liang X; Tang F; Zhang J; Zeng S; Jin S; Zhou L; Kudo Y; Qi G
Int J Oncol; 2015 Dec; 47(6):2208-16. PubMed ID: 26497847
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer.
Zhang K; Yang L; Wang J; Sun T; Guo Y; Nelson R; Tong TR; Pangeni R; Salgia R; Raz DJ
Cell Commun Signal; 2019 Dec; 17(1):167. PubMed ID: 31842906
[TBL] [Abstract][Full Text] [Related]
17. USP22 nuclear expression is significantly associated with progression and unfavorable clinical outcome in human esophageal squamous cell carcinoma.
Li J; Wang Z; Li Y
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1291-7. PubMed ID: 22447106
[TBL] [Abstract][Full Text] [Related]
18. USP22 promotes NSCLC tumorigenesis via MDMX up-regulation and subsequent p53 inhibition.
Ding F; Bao C; Tian Y; Xiao H; Wang M; Xie X; Hu F; Mei J
Int J Mol Sci; 2014 Dec; 16(1):307-20. PubMed ID: 25547493
[TBL] [Abstract][Full Text] [Related]
19. ShRNA-mediated silencing of the ubiquitin-specific protease 22 gene restrained cell progression and affected the Akt pathway in nasopharyngeal carcinoma.
Zhuang YJ; Liao ZW; Yu HW; Song XL; Liu Y; Shi XY; Lin XD; Zhou TC
Cancer Biol Ther; 2015; 16(1):88-96. PubMed ID: 25482932
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-specific protease 22 is associated with poor prognosis in neuroblastoma.
Zhibo Q; Lianxin L
Adv Clin Exp Med; 2020 Mar; 29(3):295-300. PubMed ID: 32216173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
